Select Medical
SEM was delisted on the 30th of June, 2026.
240 hedge funds and large institutions have $2.44B invested in Select Medical in 2022 Q1 according to their latest regulatory filings, with 39 funds opening new positions, 87 increasing their positions, 86 reducing their positions, and 41 closing their positions.
93% more call options, than puts
Call options by funds: $1.77M | Put options by funds: $914K
1.06% more ownership
Funds ownership: 142.83% → 143.89% (+1.1%)
1% more repeat investments, than reductions
Existing positions increased: 87 | Existing positions reduced: 86
5% less first-time investments, than exits
New positions opened: 39 | Existing positions closed: 41
2% less funds holding
Funds holding: 244 → 240 (-4)
19% less capital invested
Capital invested by funds: $3.02B → $2.44B (-$588M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
LSV Asset Management
Chicago,
Illinois
|
+$41.4M |
| 2 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$41.3M |
| 3 |
CCM
Camber Capital Management
Boston,
Massachusetts
|
+$24.5M |
| 4 |
BlackRock
New York
|
+$18.7M |
| 5 |
Fidelity Investments
Boston,
Massachusetts
|
+$9.18M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
O
OrbiMed
New York
|
-$36.3M |
| 2 |
HRCM
Hood River Capital Management
Palm Beach Gardens,
Florida
|
-$34.2M |
| 3 |
Millennium Management
New York
|
-$23.1M |
| 4 |
Arrowstreet Capital
Boston,
Massachusetts
|
-$19M |
| 5 |
Fuller & Thaler Asset Management
San Mateo,
California
|
-$14.2M |
SEM Hedge Fund Activity: Q1 2022 in Review
240 of the 6,341 institutional investors tracked by Wall St. Rank reported a position in Select Medical (SEM) for Q1 2022, worth a combined $2.44B — down 19% from $3.02B a quarter earlier.
Sellers outnumbered buyers: 41 funds closed out of SEM and 39 opened new positions — a net loss of 2 holders — while 86 trimmed existing stakes and 87 added.
The largest buyer was LSV Asset Management, adding an estimated $41.4M. The largest seller was OrbiMed, exiting entirely with an estimated $36.3M sold.
- 240 institutional investors held Select Medical (SEM) as of Q1 2022, down from 244 in Q4 2021.
- Funds reported $2.44B of Select Medical stock for Q1 2022, down 19% quarter-over-quarter.
- 39 funds opened new Select Medical positions in Q1 2022 and 41 closed out, a net change of -2 holders.
- The largest Select Medical buyer in Q1 2022 was LSV Asset Management, an estimated $41.4M added.
- The largest Select Medical seller in Q1 2022 was OrbiMed, an estimated $36.3M sold.
Based on aggregated 13F filings for Q1 2022.